Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Oligomycin A
60
CHF
CHF 60.00
In stock
AG-CN2-0517-M0011 mgCHF 60.00
AG-CN2-0517-M0055 mgCHF 180.00
AG-CN2-0517-M01010 mgCHF 300.00
Product Details | |
---|---|
Synonyms | MCH 32 |
Product Type | Chemical |
Properties | |
Formula |
C45H74O11 |
MW | 791.1 |
CAS | 579-13-5 |
RTECS | RK3328000 |
Source/Host Chemicals | Originally isolated from Streptomyces diastatochromogenes. |
Purity Chemicals | ≥95% |
Appearance | White to off-white solid. |
Solubility | Soluble in DMSO (20mg/ml), ethanol (20mg/ml) or DMF (20mg/ml). |
InChi Key | MNULEGDCPYONBU-AWJDAWNUSA-N |
Smiles | C[C@H]1CC[C@@]2([C@@H](C)[C@H](OC(/C=C/[C@H](C)[C@@H](O)[C@H](C)C([C@H](C)[C@@H](O)[C@@H]3C)=O)=O)[C@H](C)[C@H](CC[C@@H](CC)/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C3=O)O2)O[C@H]1C[C@H](O)C |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent mitochondrial ATP synthase (ATPases (F0F1)) inhibitor, consequently leading to inhibition of oxidative phosphorylation (OXPHOS).
- Useful agent for immunometabolism research. Inhibits ATP synthase by blocking its proton channel (F0 subunit), which is necessary for oxidative phosphorylation of ADP to ATP (energy production), significantly reducing electron flow through the electron transport chain.
- Anticancer agent. Shown to induce apoptosis/necroptosis in a variety of cell types, as well as autophagy.
- Shown to activate AMPK.
- Broad antifungal, antibiotic and nematocidal agent.
Product References
- Oligomycin, a new antifungal antibiotic: R.M. Smith, et al.; Antibiot. Chemother. 4, 962 (1954)
- The use of oligomycin as an inhibitor of oxidative phosphorylation: F. Huijing & E.C. Slater; J. Biochem. 49, 493 (1961)
- Inhibitors of the ATP synthethase system: P.E. Linnett & R.B. Beechey; Methods Enzymol. 55, 472 (1979)
- Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase: A.R. Salomon, et al.; Chem. Biol. 8, 71 (2001)
- Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis: L.A. Shchepina, et al.; Oncogene 21, 8149 (2002)
- Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis: S. Horman, et al.; Curr. Biol. 12, 1419 (2002)
- Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance: Y.K. Shin, et al.; Cancer Res. 65, 3162 (2005)
- Oligomycin A induces autophagy in the IPLB-LdFB insect cell line: G. Tettamanti, et al.; Cell Tissue Res. 326, 179 (2006)
- Age-dependent cell death and the role of ATP in hydrogen peroxide-induced apoptosis and necrosis: N. Miyoshi, et al.; PNAS 103, 1727 (2006)
- A new strain of Streptomyces avermitilis produces high yield of oligomycin A with potent anti-tumor activity on human cancer cell lines in vitro: X. Lin, et al.; Appl. Microbiol. Biotechnol. 81, 839 (2009)
- Mitochondrial proton and electron leaks: M. Jastroch, et al.; Essays Biochem. 47, 53 (2010)
- Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition: R. Lamb, et al.; Oncotarget 5, 11029 (2014)
- A guide to immunometabolism for immunologists: L.A. O'Neill, et al.; Nat. Rev. Immunol. 16, 553 (2016) (Review)
- The phenotype of peritoneal mouse macrophages depends on the mitochondria and ATP/ADP homeostasis: W. Chen, et al.; Cell Immunol. 324, 1 (2018)
- Role of mitochondrial function in the invasiveness of human colon cancer cells: C.S. Lin, et al.; Oncol. Rep. 39, 316 (2018)